IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

GlaxoSmithKline Pharmaceuticals

NSE:GLAXO · ISIN INE159A01016

Close
₹2,626.4
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
GlaxoSmithKline Pharmaceuticals

Financials

Revenue₹949.4 CrPrior unavailable
Profit before tax₹308.1 CrPrior unavailable
Profit after tax₹229.9 CrPrior unavailable
EPS₹13.57Prior unavailable
Structured filings

Reported financial periods

Exchange XBRL
MetricQuarter · 31 Dec 24Quarter · 30 Sept 24Quarter · 30 Jun 24Quarter · 31 Mar 24Quarter · 31 Dec 23Quarter · 30 Sept 23
Revenue₹949.4 CrN/AN/AN/AN/AN/A
Profit before tax₹308.1 CrN/AN/AN/AN/AN/A
Profit after tax₹229.9 CrN/AN/AN/AN/AN/A
Finance cost₹0.1 CrN/AN/AN/AN/AN/A
ImpairmentN/AN/AN/AN/AN/AN/A
EPS₹13.57N/AN/AN/AN/AN/A
₹ crore except EPS · Consolidated · preferred filing per periodNSE XBRL
Accounting lens

What deserves analyst attention

Research framework
Period comparability

Confirm quarterly, year-to-date and annual periods before calculating growth. The table preserves the exchange period labels.

Standalone vs consolidated

Treat scope changes as breaks in comparability and open the linked XBRL before relying on a trend.

Company-specific concepts

Sector metrics and accounting choices require additional facts beyond this common cross-company layer.